Inflammatory Gene Polymorphisms and Susceptibility to Kawasaki Disease and Its Arterial Sequelae

OBJECTIVE. We tested the hypothesis that single-nucleotide polymorphisms of inflammatory genes C-reactive protein (CRP) and tumor necrosis factor α (TNF-α) may exert influence on susceptibility to Kawasaki disease and its arterial sequelae. METHODS. We analyzed the CRP +1444 C→T and TNF-α −308 G→A polymorphisms in 167 patients aged 8.9 ± 4.1 years with a history of Kawasaki disease (73 with and 94 without coronary aneurysms) and 124 healthy control subjects. For patients with Kawasaki disease, we further determined whether these single-nucleotide polymorphisms were associated with coronary aneurysms, carotid arterial stiffening, and intima-media thickness. RESULTS. Genotypic and allelic frequencies of CRP +1444 for T carrier and TNF-α −308 for A carrier were significantly higher in patients than in control subjects. The genotypic and allelic distributions did not differ between patients with and those without coronary aneurysms; however, patients with CRP +1444 CT/TT genotype compared with those with a CC genotype and patients with TNF-α −308 GA/AA genotype compared with those with a GG genotype had significantly greater carotid arterial stiffness and intima-media thickness. Carriers of both CRP +1444 T allele and TNF-α −308 A allele had the highest susceptibility to Kawasaki disease and a significant trend of increased arterial stiffness and intima-media thickness compared with those who carried either 1 or none of the rare alleles. Multiple linear regression analysis identified CRP +1444 allele carrier as a significant determinant of both carotid stiffness and carotid intima-media thickness and TNF-α −308 A allele carrier as a determinant of only intima-media thickness. CONCLUSIONS. Our findings suggest that CRP +1444 C→T and TNF-α −308 G→A polymorphisms are associated with predisposition to Kawasaki disease and, in patients with Kawasaki disease, increased carotid arterial stiffness and intima-media thickness in the long-term.

[1]  K. Yabuta,et al.  Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. , 1990, Clinical immunology and immunopathology.

[2]  R. Welch,et al.  Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease , 2007, Clinical and experimental immunology.

[3]  J. Ottenkamp,et al.  Association of mannose-binding lectin genotype with cardiovascular abnormalities in Kawasaki disease , 2003, The Lancet.

[4]  T. Lehtimäki,et al.  C-reactive protein genetics is associated with carotid artery compliance in men in The Cardiovascular Risk in Young Finns Study. , 2008, Atherosclerosis.

[5]  Yasmin,et al.  Rheumatoid Arthritis Is Associated With Increased Aortic Pulse-Wave Velocity, Which Is Reduced by Anti–Tumor Necrosis Factor-&agr; Therapy , 2006, Circulation.

[6]  A. Blakemore,et al.  Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. , 1992, Human molecular genetics.

[7]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[8]  M. Vitale,et al.  Response to anti-tumour necrosis factor alpha blockade is associated with reduction of carotid intima-media thickness in patients with active rheumatoid arthritis. , 2007, Rheumatology.

[9]  Lei Zhao,et al.  The Relationship between Gene Polymorphism and CRP Level in a Chinese Han Population , 2007, Biochemical Genetics.

[10]  S. Sui,et al.  Dissociation and subunit rearrangement of membrane-bound human C-reactive proteins. , 2001, Biochemical and biophysical research communications.

[11]  A. Saunders,et al.  Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF). , 1992, Human molecular genetics.

[12]  Yu-Lung Lau,et al.  Modulating Effects of Mannose Binding Lectin Genotype on Arterial Stiffness in Children After Kawasaki Disease , 2004, Pediatric Research.

[13]  S. Bechtold,et al.  Subclinical atherosclerosis, but normal autonomic function after Kawasaki disease. , 2007, The Journal of pediatrics.

[14]  K. Siala,et al.  Cytokine Tumor Necrosis Factor-alpha A Promoter Gene Polymorphism at Position −308 G→A and Pediatric Inflammatory Bowel Disease: Implications in Ulcerative Colitis and Crohn's Disease , 2006, Journal of pediatric gastroenterology and nutrition.

[15]  Y. Chien,et al.  Association between levels of TNF-alpha and TNF-alpha promoter -308 A/A polymorphism in children with Kawasaki disease. , 2003, Journal of the Formosan Medical Association = Taiwan yi zhi.

[16]  W. Fiers,et al.  Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome , 1986, The Journal of experimental medicine.

[17]  S. Tam,et al.  Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease , 2004, Heart.

[18]  Motoki Fujiwara,et al.  Increased Frequency of Alleles Associated with Elevated Tumor Necrosis Factor-α Levels in Children with Kawasaki Disease , 2001, Pediatric Research.

[19]  Y. Cheung,et al.  Relationship between carotid intima-media thickness and arterial stiffness in children after Kawasaki disease , 2006, Archives of Disease in Childhood.

[20]  G. Salles,et al.  Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. , 1998, Blood.

[21]  S. Humphries,et al.  C-reactive protein (+1444C>T) polymorphism influences CRP response following a moderate inflammatory stimulus. , 2005, Atherosclerosis.

[22]  T. Sugimura,et al.  Vasodilatory response of the coronary arteries after Kawasaki disease: evaluation by intracoronary injection of isosorbide dinitrate. , 1992, The Journal of pediatrics.

[23]  J. Belaiche,et al.  Tumour necrosis factor (TNF) gene polymorphism influences TNF‐α production in lipopolysaccharide (LPS)‐stimulated whole blood cell culture in healthy humans , 1998, Clinical and experimental immunology.

[24]  S. Duan,et al.  Tumor necrosis factor alpha −308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China , 2007, Rheumatology International.

[25]  T. Okada,et al.  Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. , 2001, Pediatrics.

[26]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..

[27]  T. Matsuishi,et al.  Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. , 2006, The Journal of pediatrics.

[28]  O. Wagner,et al.  The C-reactive protein (+)1444C/T alteration modulates the inflammation and coagulation response in human endotoxemia. , 2006, Clinical chemistry.

[29]  A. Hamsten,et al.  A Common Functional Polymorphism (C→A Substitution at Position −863) in the Promoter Region of the Tumour Necrosis Factor-α (TNF-α) Gene Associated With Reduced Circulating Levels of TNF-α , 1999 .

[30]  Y. Chien,et al.  ASSOCIATION BETWEEN LEVELS OF TNF-α AND TNF-α PROMOTER -308 A/A POLYMORPHISM IN CHILDREN WITH KAWASAKI DISEASE , 2003 .

[31]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[32]  K. Itoh,et al.  Analysis of tumor necrosis factor‐α production and polymorphisms of the tumor necrosis factor‐α gene in individuals with a history of Kawasaki disease , 1999, Pediatrics international : official journal of the Japan Pediatric Society.

[33]  S. Daniels.  Coronary artery lesions in Kawasaki disease , 2003 .

[34]  Tomio Kobayashi,et al.  Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease , 2006, Circulation.

[35]  L. Abraham,et al.  Impact of the ‐308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease , 1999, Journal of leukocyte biology.

[36]  J. Deanfield,et al.  Endothelial dysfunction late after Kawasaki disease. , 1996, Circulation.

[37]  P. Ridker,et al.  Novel clinical markers of vascular wall inflammation. , 2001, Circulation research.

[38]  C. Carlson,et al.  Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. , 2006, JAMA.

[39]  S Sasayama,et al.  Non-invasive assessment of the age related changes in stiffness of major branches of the human arteries. , 1987, Cardiovascular research.

[40]  T Enright,et al.  Kawasaki syndrome. , 1990, Annals of allergy.

[41]  A. Slyper.  Clinical review 168: What vascular ultrasound testing has revealed about pediatric atherogenesis, and a potential clinical role for ultrasound in pediatric risk assessment. , 2004, The Journal of clinical endocrinology and metabolism.

[42]  S. Tam,et al.  Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. , 2004, Journal of the American College of Cardiology.

[43]  A. Szalai,et al.  C-reactive protein gene polymorphisms, C-reactive protein blood levels, and cardiovascular disease risk. , 2007, Journal of the American College of Cardiology.

[44]  R. Porcher,et al.  Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. , 2002, Blood.

[45]  D. Kwiatkowski,et al.  Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria , 1994, Nature.

[46]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[47]  A. Hamsten,et al.  Plasma tumour necrosis factor-alpha and early carotid atherosclerosis in healthy middle-aged men. , 2002, European heart journal.

[48]  P. Mcgeer,et al.  Generation of C-reactive protein and complement components in atherosclerotic plaques. , 2001, The American journal of pathology.

[49]  S. Chanock,et al.  Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. , 1998, The Journal of clinical investigation.

[50]  神薗 愼太郎.  Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease , 2000 .

[51]  K Hashino,et al.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. , 1996, Circulation.

[52]  S. Humphries,et al.  Human CRP Gene Polymorphism Influences CRP Levels: Implications for the Prediction and Pathogenesis of Coronary Heart Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[53]  V. Videm,et al.  Association of mannose-binding-lectin deficiency with severe atherosclerosis , 1998, The Lancet.